There is accumulating evidence for the critical role of cells that possess embryonic stem cell (ESC) characteristics and the expression of components of the renin-angiotensin system (RAS), in different types of vascular anomalies (VAs) (1), cancer (2–6), and fibroproliferative conditions (7–9). Here, REN is linked to cancer.